ĐÁNH GIÁ TÁC ĐỘNG CỦA HLA TYP I VÀ KHÁNG THỂ KHÁNG HLA TRÊN BỆNH NHÂN GHÉP THẬN
Thông tin bài báo
Ngày nhận bài: 07/08/24                Ngày hoàn thiện: 17/11/24                Ngày đăng: 18/11/24Tóm tắt
Từ khóa
Toàn văn:
PDFTài liệu tham khảo
[1] S. Abramyan et al., Kidney Transplantation, Treasure Island (FL): StatPearls, 2023.
[2] M. M. Ahmed et al., “Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies,” Journal of Immunology Research, vol. 2018, no. 1, pp. 1-18, 2018.
[3] S. C. Palme et al., “Interventions for preventing bone disease in kidney transplant recipients,” Cochrane Database Syst Rev., vol. 2019, no. 10, 2019, doi: 10.1002/14651858.CD005015.pub4.
[4] C.-M. Chen et al., “The Difficulties and Needs of Organ Transplant Recipients during Postoperative Care at Home: A Systematic Review,” Int J Environ Res Public Health, vol. 17, no. 16, 2020, Art. no. 5798.
[5] M. Á. Frutos et al., “Recommendations for living donor kidney transplantation,” Nefrología (English Edition), vol. 42, Supplement 2, pp. 5-132, 2022.
[6] A. Ladányi et al., “HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab,” Pathol Oncol Res., vol. 28, 2022, Art. no. 1610297.
[7] K. Balassa et al., “Haematopoietic stem cell transplants: principles and indications,” British Journal of Hospital Medicine, vol. 80, no. 1, 2018, doi: h10.12968/hmed.2019.80.1.33.
[8] M. M. Althaf et al., “Human leukocyte antigen typing and crossmatch: A comprehensive review,” World J Transplant, vol. 7, no. 6, pp. 339-348, 2017.
[9] V. S. Nguyen, "Research on HLA genotype using PCR - SSP technique and ABO blood group system in kidney transplant patients at Hue Central Hospital," Master's thesis, University of Science - Hue University, 2018.
[10] V. H. Nguyen, N. D. Thang, T. T. H. Phan, V. S. Nguyen, T. M. T. Ngo, K. T. Nguyen, T. N. Y. Nguyen, and N. H. Nguyen, "Human leukocyte antigens class i (hla-i) polymorphism on chronic kidney patients," Vietnam Journal of Biotechnology, vol. 2, pp. 361-366, 2021.
[11] J. R. A. Peña et al., “Anti-HLA antibody testing in hematology patients,” Am J Hematol., vol. 90, no. 4, pp. 361-364, 2016.
[12] F. Ozkul et al., “Effect of age on the outcome of renal transplantation: A single-center experience,” Pak J Med Sci., vol. 32, no. 4, pp. 827-830, 2016.
[13] M. E. Astley et al., “The ERA Registry Annual Report 2020: a summary,” Clinical Kidney Journal, vol. 16, no. 8, pp. 1330-1354, 2023.
[14] A. Jagdale et al., “Chronic Dialysis in Patients with End-Stage Renal Disease: Relevance to Kidney Xenotransplantation,” Xenotransplantation, vol. 26, no. 2, 2019, Art. no. e12471.
[15] X. Zhang et al., “Prevalence and Risk Factors of Gallbladder Stones and Polyps in Liaoning, China,” Front Med (Lausanne), vol. 9, 2022, Art. no. 865458
[16] V. Kosmoliaptsis et al., “Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation,” Clinical Investigation, vol. 86, no. 5, p. 1039, 2014.
[17] M. Kavuzlu et al., “HLA-B*51 Frequency in Transplant Patients and Donors,” Exp Clin Transplant, vol. 22(Suppl 1), pp. 265-269, 2024.
[18] N. V. Le and N. N. Bach, “Characteristics of HLA-Antigens and compatibility in living related-kidnay transplantation at Viet Duc Hospital,” Vietnam Medical Journal, vol. 538, no. 3, pp. 181-185, 2024.
[19] S. Y. Kim et al., “Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients,” BMC Pulm Med., vol. 18, p. 45, 2018.
[20] M. V. de Sousa et al., “Treatment of Antibody-Mediated Rejection After Kidney Transplantation: Immunological Effects, Clinical Response, and Histological Findings,” Ann Transplant, vol. 25, 2020, Art. no. e925488.DOI: https://doi.org/10.34238/tnu-jst.10886
Các bài báo tham chiếu
- Hiện tại không có bài báo tham chiếu